Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 5080764, 11 pages
https://doi.org/10.1155/2018/5080764
Research Article

An Investigation of the Prescription Patterns of Chinese Herbal Products for Chronic Glomerulonephritis Patients: A Hospital-Based Cross-Sectional Study

1Division of Chinese Internal Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
2School of Chinese Medicine, China Medical University, Taichung, Taiwan
3School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan
4Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan
5Department for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Chia-Yi, Taiwan
6Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan
7Center of Excellence for Chang Gung Research Data link, Chang Gung Memorial Hospital, Chia-Yi, Taiwan
8Chang Gung Immunology Consortium, Chang Gung Memorial Hospital and Chang Gung University, Gueishan, Taoyuan, Taiwan
9Graduate Institute of Acupuncture Science, College of Medicine, China Medical University, Taichung, Taiwan

Correspondence should be addressed to Jiun-Liang Chen; wt.gro.hmgc@51021a

Received 13 July 2018; Revised 28 September 2018; Accepted 23 October 2018; Published 15 November 2018

Academic Editor: Bhushan Patwardhan

Copyright © 2018 Wen Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Jha, G. Garcia-Garcia, K. Iseki et al., “Chronic kidney disease: global dimension and perspectives,” The Lancet, vol. 382, no. 9888, pp. 260–272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C. P. Wen, T. Y. D. Cheng, M. K. Tsai et al., “All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan,” The Lancet, vol. 371, no. 9631, pp. 2173–2182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. KDIGO CKD Work Group, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” Kidney International Supplements, vol. 3, pp. 1–150, 2013. View at Publisher · View at Google Scholar
  4. D. Kasper, A. Fauci, S. Hauser, D. Longo, J. L. Jameson, and J. Loscalzo, Harrison’s Principles of Internal Medicine, McGraw-Hill Education, New York, NY, USA, 19th edition, 2015.
  5. M. MacKinnon, S. Shurraw, A. Akbari, G. A. Knoll, J. Jaffey, and H. D. Clark, “Combination Therapy With an Angiotensin Receptor Blocker and an ACE Inhibitor in Proteinuric Renal Disease: A Systematic Review of the Efficacy and Safety Data,” American Journal of Kidney Diseases, vol. 48, no. 1, pp. 8–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P.-C. Hsu, Y. Tsai, J. Lai, C. Wu, S. Lin, and C. Huang, “Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study,” Journal of Ethnopharmacology, vol. 156, pp. 358–364, 2014. View at Publisher · View at Google Scholar
  7. M.-Y. Lin, Y.-W. Chiu, J.-S. Chang et al., “Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease,” Kidney International, vol. 88, no. 6, pp. 1365–1373, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. T. H. Yang, H. U. Chen, S. H. Yang et al., “Utilization pattern for traditional chinese medicine among late stage chronic kidney disease patients: a hospital-based cross-sectional study,” Journal of Chinese Medicine, vol. 25, no. 1, pp. 41–58, 2014. View at Google Scholar
  9. Z. Ma, H. Xia, S. Cui, and J. Yu, “Attenuation of renal ischemic reperfusion injury by salvianolic acid B via suppressing oxidative stress and inflammation through PI3K/Akt signaling pathway,” Brazilian Journal of Medical and Biological Research, vol. 50, no. 6, 2017. View at Publisher · View at Google Scholar
  10. Y.-X. Fei, S.-Q. Wang, L.-J. Yang et al., “Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats,” Journal of Ethnopharmacology, vol. 207, pp. 57–66, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Shahzad, A. Shabbir, K. Wojcikowski, H. Wohlmuth, and G. C. Gobe, “The antioxidant effects of radix astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease,” Current Drug Targets, vol. 17, no. 12, pp. 1331–1340, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. H. W. E. Zhang, Z. X. I. Lin, C. Xu, C. Leung, and L. S. U. Chan, “Astragalus (a traditional Chinese medicine) for treating chronic kidney disease,” Cochrane Database of Systematic Reviews, vol. 10, Article ID CD008369, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Zhu, Y. Lin, C.-F. Zhu et al., “Emodin inhibits extracellular matrix synthesis by suppressing p38 and ERK1/2 pathways in TGF-β 1-stimulated NRK-49F cells,” Molecular Medicine Reports, vol. 4, no. 3, pp. 505–509, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Hu, M. Noor, Y. F. Wong et al., “In vitro anti-fibrotic activities of herbal compounds and herbs,” Nephrology Dialysis Transplantation , vol. 24, no. 10, pp. 3033–3041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Wang, Y. Zhao, X. Xiao et al., “Assessment of the renal protection and hepatotoxicity of rhubarb extract in rats,” Journal of Ethnopharmacology, vol. 124, no. 1, pp. 18–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-J. Park, H.-S. Shim, S. Y. Chung, T. H. Lee, and I. Shim, “Soyo-san reduces depressive-like behavior and proinflammatory cytokines in ovariectomized female rats,” BMC Complementary and Alternative Medicine, vol. 14, article 34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. Y.-J. Lin, T.-J. Ho, Y.-C. Yeh et al., “Chinese herbal medicine treatment improves the overall survival rate of individuals with hypertension among type 2 diabetes patients and modulates in vitro smooth muscle cell contractility,” PLoS ONE, vol. 10, no. 12, Article ID e0145109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Yasui, M. Yamada, H. Uemura et al., “Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine,” Maturitas, vol. 62, no. 2, pp. 146–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Chen, Y.-Y. Zeng, H.-L. Zeng et al., “Inhibitory effects of pretreatment with Buyanghuanwu decoction on inflammatory cytokine expressions in the kidneys of rats after induction of brain death,” Journal of Chinese Medicinal Materials, vol. 32, no. 12, pp. 1855–1860, 2009. View at Google Scholar · View at Scopus
  20. X. G. Shen, The Research on the Effect of Buyanghuanwu on the Kidney's Expression of ICAM, VCAM-1 of Rats with the Experimental Diabetes, The University of Hebei Medical, 2009.
  21. L. Min, W. Ling, R. Hua et al., “Anti-angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential,” Molecular Medicine Reports, vol. 13, no. 3, pp. 2518–2526, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Wenjin and W. Jianwei, “Protective Effect of Gentianine, a compound from Du Huo Ji Sheng Tang, against Freund’s Complete Adjuvant-Induced Arthritis in Rats,” Inflammation, vol. 40, no. 4, pp. 1401–1408, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Wang, T. T. Zhao, H. J. Zhang, and P. Li, “Therapeutic effect of TGF-β signaling pathway inhibitor on renal fibrosis,” Chinese Journal of Integrated Traditional and Western Nephrology, vol. 17, no. 2, pp. 177–180, 2016. View at Google Scholar
  24. J.-Y. Wang, W.-M. Chen, C.-S. Wen, S.-C. Hung, P.-W. Chen, and J.-H. Chiu, “Du-Huo-Ji-Sheng-Tang and its active component Ligusticum chuanxiong promote osteogenic differentiation and decrease the aging process of human mesenchymal stem cells,” Journal of Ethnopharmacology, vol. 198, pp. 64–72, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Li, B. Zhang, D. Jiang, Y. Wei, and N. Zhang, “Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae,” BMC Bioinformatics, vol. 11, 11, p. S6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. T. Tseng, F. R. Chang, and Y. C. Lo, “The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death,” Phytomedicine, vol. 21, no. 5, pp. 724–733, 2014. View at Publisher · View at Google Scholar
  27. H. Shu, H. Arita, M. Hayashida et al., “Anti-hypersensitivity effects of Shu-jing-huo-xue-tang, a Chinese herbal medicine, in CCI-neuropathic rats,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 464–470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Kanai, N. Taniguchi, and H. Higashino, “Study of Sokei-Kakketu-To (Shu-Jing-Huo-Xue-Tang) in adjuvant arthritis rats,” American Journal of Chinese Medicine, vol. 31, no. 6, pp. 879–884, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Su, C. Mao, F. Yin et al., “Effects of unprocessed versus vinegar-processed Schisandra chinensis on the activity and mRNA expression of CYP1A2, CYP2E1 and CYP3A4 enzymes in rats,” Journal of Ethnopharmacology, vol. 146, no. 3, pp. 734–743, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Saruwatari, A. Takashima, K. Yoshida et al., “Effects of seijo-bofu-to, a traditional japanese herbal medicine containing furanocoumarin derivatives, on the drug-metabolizing enzyme activities in healthy male volunteers,” Basic & Clinical Pharmacology & Toxicology, vol. 115, no. 4, pp. 360–365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Li, J. Hu, B. Wang et al., “Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp,” Toxicology and Applied Pharmacology, vol. 275, no. 2, pp. 163–175, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. C.-X. Liu, X.-L. Yi, D.-Y. Si, X.-F. Xiao, X. He, and Y.-Z. Li, “Herb-drug interactions involving drug metabolizing enzymes and transporters,” Current Drug Metabolism, vol. 12, no. 9, pp. 835–849, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. L. Hou, C. M. Lu, and T. H. Tsai, “Effects of jia-wei-xiao-yao-san on the peripheral and lymphatic pharmacokinetics of paclitaxel in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 5614747, 10 pages, 2016. View at Publisher · View at Google Scholar
  34. M. H. Chiang, L. W. Chang, J. W. Wang, L. C. Lin, and T. H. Tsai, “Herb-drug pharmacokinetic interaction of a traditional chinese medicine jia-wei-xiao-yao-san with 5-fluorouracil in the blood and brain of rat using microdialysis,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 729679, 11 pages, 2015. View at Publisher · View at Google Scholar
  35. E. V. Nagler, A. C. Webster, R. Vanholder, and C. Zoccali, “Antidepressants for depression in stage 3-5 chronic kidney disease: A systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP),” Nephrology Dialysis Transplantation , vol. 27, no. 10, pp. 3736–3745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. S. S. Hedayati and F. O. Finkelstein, “Epidemiology, diagnosis, and management of depression in patients with CKD,” American Journal of Kidney Diseases, vol. 54, no. 4, pp. 741–752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-L. Chen, C.-Y. Lee, K.-H. Huang, Y.-H. Kuan, and M. Chen, “Prescription patterns of Chinese herbal products for patients with sleep disorder and major depressive disorder in Taiwan,” Journal of Ethnopharmacology, vol. 171, pp. 307–316, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. J.-C. Luo, H.-B. Leu, M.-C. Hou et al., “Nonpeptic ulcer, nonvariceal gastrointestinal bleeding in hemodialysis patients,” American Journal of Medicine, vol. 126, no. 3, pp. 264.e25–264.e32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. H.-J. Cui, A.-L. Yang, H.-J. Zhou et al., “Buyang huanwu decoction promotes angiogenesis via vascular endothelial growth factor receptor-2 activation through the PI3K/Akt pathway in a mouse model of intracerebral hemorrhage,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. H. D. Qu, L. Tong, J. G. Shen, and Y. Y. Chen, “Protective effect of Buyanghuanwu Tang on cultured rat cortical neurons against hypoxia induced apoptosis,” Di Yi Jun Yi Da XueXueBao, vol. 22, no. 1, pp. 35–38, 2002 (Chinese). View at Google Scholar
  41. Y. N. Zhao, X. G. Wu, J. M. Li, C. X. Chen, Y. Z. Rao, and S. X. Li, “Effect of Bu Yang HuanWu recipe on cerebral microcirculation in gerbils with ischemia reperfusion,” Sichuan Da XueXueBao Yi Xue Ban, vol. 41, no. 1, pp. 53–56, 2010 (Chinese). View at Google Scholar
  42. C. L. Liao, L. Tong, and Y. Y. Chen, “Effect of Buyanghuanwu decoction on neuronal nitric oxide synthase expression after permanent focal cerebral ischemiain rats,” Di Yi Jun Yi Da XueXueBao, vol. 24, no. 8, pp. 864–868, 2004 (Chinese). View at Google Scholar
  43. Y. C. Zhou, B. Liu, Y. J. Li et al., “Effects of buyang huanwu decoction on ventricular remodeling and differential protein profile in a rat model of myocardial infarction,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 385247, 11 pages, 2012. View at Publisher · View at Google Scholar
  44. M. Li, W. Wang, J. Xue, Y. Gu, and S. Lin, “Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 412–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. T. Gao, J. K. H. Cheung, J. Li et al., “A Chinese herbal decoction, Danggui Buxue Tang, prepared from Radix Astragali and Radix Angelicae Sinensis stimulates the immune responses,” Planta Medica, vol. 72, no. 13, pp. 1227–1231, 2006. View at Publisher · View at Google Scholar · View at Scopus